3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neuroblastoma
2
Myelodysplastic Syndromes
2
Multiple Myeloma
2
Leukemia, Myelomonocytic, Chronic
2
Anemia, Refractory, with Excess of Blasts
2
Wilms Tumor
1
Uveal Melanoma
1
Sarcoma, Ewing
1
Rhabdomyosarcoma
1
Recurrence
1
Primary Malignant Peripheral Nerve Sheath Tumors
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Oligodendroglioma
1
Neoplasms, Germ Cell and Embryonal
1
Neoplasm Metastasis
1
Mycosis Fungoides
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Extranodal NK-T-Cell
1
Leukemia, Myeloid, Acute
1
Leukemia, Megakaryoblastic, Acute
1
Leukemia, Erythroblastic, Acute
1
Hepatoblastoma
1
Gliosarcoma
1
Glioma
1
Glioblastoma
1
GATA2 Deficiency
1
Breast Neoplasms
1
Brain Neoplasms
1
Astrocytoma
1
Anemia, Refractory
1
Interventions
Specimen Handling
3
Doxorubicin
3
Biopsy
3
Radiotherapy
2
Radiation
2
Magnetic Resonance Spectroscopy
2
Gemcitabine
2
toripalimab
1
talimogene laherparepvec
1
ribociclib
1
peposertib
1
pazopanib
1
liposomal doxorubicin
1
cabozantinib
1
abemaciclib
1
Temozolomide
1
Surgical Procedures, Operative
1
PM 01183
1
Nivolumab
1
Neoadjuvant Therapy
1
Ifosfamide
1
Everolimus
1
Docetaxel
1
ADI PEG20
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leiomyosarcoma
×
Vorinostat
×
90 days
×
Clear all
No trials found.